Themis Medicare Limited THEMISMED.NS · Stock Open Themis Medicare Limited in new tab
Themis Medicare Limited Analysis (THEMISMED.NS)
Is Themis Medicare Limited a good investment? Themis Medicare Limited (THEMISMED.NS) is currently trading at 113.11 INR.
In terms of valuation, the stock trades at a P/E ratio of 920.83. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Themis Medicare Limited is expected to release its next earnings report on May 18, 2026.
For income investors, Themis Medicare Limited pays a dividend yield of 0.43%. With a payout ratio of 402%, the dividend appears to be under pressure.
Investor FAQ
Does Themis Medicare Limited pay a dividend?
Yes, it pays an annual dividend of 0.50 INR (0.43% yield).
What asset class is Themis Medicare Limited?
Themis Medicare Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be May 18, 2026. The company currently has a trailing EPS of 0.12.
Company Profile
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including anti-tuberculosis, analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic, anti-diabetic, anti-emetic, anti-hypertensive, anti-allergic and anti-inflammatory, anti-allergic and appetite stimulant, anticoagulant, antifibrolytic, antimalarial, anti-muscarinic, antioxidant, calcium, cardiovascular, corticosteroid, electrolytes, expectorant, hematinic, hemostatic agent, hemostatic agent with anesthetic, hormones, immunomodulator with anti-viral, muscle relaxant, narcotic analgesic, neuropathy, nutraceuticals, PPI, probiotic, reversal for muscle relaxant, sedatives, skeletal muscle relaxant, skeletal muscle relaxant and analgesic and anti-inflammatory, vasodilator, vasopressors, and vitamins. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is based in Mumbai, India.
| Year | Total Dividends |
|---|---|
| ▸2026 |
0.77 INR
|
| Oct. 12, 2026 (estimated) | 0.7700 |
| ▸2025 |
0.50 INR
|
| Oct. 12, 2025 | 0.5000 |
| ▸2024 |
0.50 INR
|
| Aug. 3, 2024 | 0.5000 |
| ▸2023 |
5.00 INR
|
| Oct. 9, 2023 | 5.0000 |
| ▸2022 |
5.00 INR
|
| Oct. 19, 2022 | 5.0000 |
| ▸2021 |
4.30 INR
|
| Oct. 18, 2021 | 4.3000 |
| ▸2020 |
1.75 INR
|
| Oct. 28, 2020 | 1.7500 |
| ▸2011 |
3.00 INR
|
| Aug. 29, 2011 | 3.0000 |
| ▸2010 |
3.00 INR
|
| July 25, 2010 | 3.0000 |
| ▸2008 |
2.50 INR
|
| Sept. 1, 2008 | 2.5000 |
| ▸2007 |
2.00 INR
|
| Sept. 14, 2007 | 2.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Themis Medicare Limited | Oct 12, 2025 | Paid | 0.5 INR |
| Split Date | Split Ratio to 1 |
|---|---|
| Oct. 10, 2023 | 10.000000 |
Community Discussion